Brands: Pulmicort Respules · Budesonide
Average across 17 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | generic | 7 | SUPPLYING |
| Sandoz Inc | generic | 3 | SUPPLYING |
| A-S Medication Solutions | repackager | 3 | SUPPLYING |
| AstraZeneca Pharmaceuticals LP | unknown | 3 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | generic | 3 | SUPPLYING |
| Amneal Pharmaceuticals of New York LLC | generic | 2 | SUPPLYING |
| Chartwell RX, LLC | generic | 2 | SUPPLYING |
| Cardinal Health 107, LLC | repackager | 1 | SUPPLYING |
| American Health Packaging | repackager | 1 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | repackager | 1 | SUPPLYING |
| Aurobindo Pharma Limited | generic | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide within the United States
Does Not Meet Monograph: Budesonide may be slightly above or below the specification range. — Recalling firm: AstraZeneca LP — Nationwide
Does Not Meet Monograph: Budesonide may be slightly above or below the specification range. — Recalling firm: AstraZeneca LP — Nationwide
